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Abstract
Extraskeletal osteosarcoma is a rare malignant soft tissue tumor. Here we present a case of a primary extraskeletal
osteosarcoma arising from omentum majus in a 40-year-old Chinese woman. Ultrasonography of the pelvic cavity
showed a large soft tissue mass with marked calcification. Complete surgical resection of the primary tumor was
performed and the histopathological diagnosis was extraskeletal osteosarcoma of omentum majus. She was
followed up without adjuvant radiotherapy and chemotherapy, and died from widespread intra-abdominal, lung
and liver metastases 7 months postoperatively.
Background
Extraskeletal osteosarcoma (ESOS) is a rare malignant
mesenchymal neoplasm in soft tissues but not directly
attached to the skeletal system. Fewer than 300 cases
have been reported to date. Here, we describe a case of
a primary ESOS arising from omentum majus. To the
best of our knowledge, this is the second reported case
in the English literature.
Case history
A 40-year-old woman was admitted to our hospital
complaining of lower abdominal pain with nausea and
vomiting for 4 days. She denied any history of other pre-
vious abdominal injuries or pain and had no other perti-
nent past medical history. The patient’s general
condition was good and no weight loss was observed.
Ultrasonography of the pelvic cavity showed a soft tissue
mass with marked calcification, measuring 6.9 × 4.6 cm.
Laboratory tests revealed an increase in the alkaline
phosphatase (213 u/L) and carbohydrate antigen 125
(102 u/moL). For resection of the tumor, en bloc mass
excision with segmental omentum majus resection was
performed. During the operation, the mass was located
in the lower margin of greater omentum, and tumor
invasion into surrounding organs was not observed.
There was no lymph node swelling or peritoneal disse-
mination. About 500 ml of bloody effusion was present
in the peritoneal cavity. Frozen section showed a malig-
nant mesenchymal tumor of omentum majus.
The resected tumor was 6.0 × 4.0 × 3.0 cm in size. The
cut surface consisted of a gray-white to tan-yellow solid
area with a gritty sensation. Microscopically, there was
calcificied neoplastic osteoid among the tumor cells and
osteoclastic giant cells that showed intensive positive
reaction with Vimentin and CD99 (histiocytic marker)
(Figure 1), but negative for CK, CR, EMA, CD117, CD34,
CD68, SMA and Desmin. The final pathological diagnosis
was extraskeletal osteosarcoma of omentum majus.
The postoperative course was uneventful. We recom-
mended adjuvant radiotherapy and chemotherapy, but
the patient refused. Five months after the operation, she
was readmitted to our hospital due to abdominal pain.
Abdominal CT revealed a large mass with mottled calci-
fication and effusions in the peritoneal cavity (Figure 2).
She died with widespread intra-abdominal, lung and
liver metastases 7 months postoperatively.
Discussion
Primary tumors develop in the greater omenturn is very
rare. Most common histopathologic types are leiomyo-
sarcoma, leiomyoma, gastrointestinal stromal tumor,
and teratoma. ESOS is a rare malignant neoplasm aris-
ing from soft tissue that produces osteoid, without any
continuity to skeletal bones and constitutes 4% of osteo-
sarcomas and 1.2% of all soft-tissue sarcomas [1,2].
ESOS occurs mostly in soft tissue of the thigh, followed
by the upper limb and retroperitoneum [3,4]. Cases of
ESOS arising in unusual sites, such as the larynx, kidney,
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esophagus, small intestine, liver, heart, urinary bladder,
parotid, and breast have also been reported [2]. In a
review of the literature, there is only one report of
extraskeletal osteosarcoma arising from the omentum
majus [5].
Unlike conventional osteosarcoma of bone, which
usually occurs in the first or second decade of life,
ESOS occurs predominantly in patients older than 40
years of age [1,3]. The patient reported here was just 40
years old. As with most other tumors, the etiology of
ESOS is essentially unknown. It has been reported to
have occurred in previously irradiated areas [6], and
mechanical injury has also been considered as a causa-
tive agent [7]. However, our patient has no history of
surgery or regional radiation treatment.
The diagnosis is generally delayed because symptoms
are often absent or vague. Typically, the tumor presents
as a progressively enlarging soft tissue mass associated
with pain in approximately one-third of patients. Serum
alkaline phosphatase levels may be elevated. Imaging
studies show soft tissue masses with internal cloud-like
calcifications or ossification. Histopathologically, there
are 2 microscopic components, sarcomatous cells and
extracellular matrix, consisting of osteoid or immature
bone [8]. Immunohistochemically, the expression of
antigens varies in the reported cases. Our case expressed
CD99 and vimentin, but was negative for CK, CR, EMA,
CD117, CD34, CD68, SMA and Desmin.
The prognosis of ESOS is grave with a cause-specific
survival rate at 5 years less than 25% [9]. Radical resec-
tion appears to be the best therapeutic option for local
control but has no effect on distant metastasis [10].
Hence, systemic chemotherapy is commonly advocated,
although the efficacy has not been evaluated with
Figure 1 Histological section (A) showing tumor arising from the omentum (×40, H&E); B) showing calcificied neoplastic osteoid
among the tumour cells and osteoclastic giant cells (×400, H&E)). Immunohistochemical section showed intensive positive reaction with
Vimentin (C) and CD99 (D) (×200).
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controlled clinical trials due to the rarity of cases. Radio-
therapy may provide temporary palliation [11].
Goldstein-Jackson et al. [11] reported that ESOS is better
treated with more aggressive multi-agent chemotherapy.
In our case, we performed a wide marginal resection, but
the patient refused chemotherapy and radiotherapy.
More information needs to be obtained concerning the
clinical outcome for appropriate management, planning,
and prognostic estimation.
Conclusion
In conclusion, we have reported an exceedingly rare
case of extraskeletal osteosarcoma arising from omen-
tum majus. The diagnosis of ESOS should be considered
when one encounters a large soft tissue mass that shows
abundant intratumoral calcification or ossification. The
tumor recurred and spread rapidly despite wide surgical
resection, showing highly aggressive biologic behavior
and causing death within 7 months.
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Figure 2 Abdominal CT revealed a large mass with mottled
calcification, and effusions in the peritoneal cavity.
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